|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/107 | |
| A61K 31/197 | |||
| A61K 9/50 | |||
| A61K 47/10 | |||
| A61K 47/12 | |||
| A61K 47/14 | |||
| A61K 9/00 | |||
| A61K 9/16 | |||
| A61K 9/20 | |||
| A61K 9/48 |
| (11) | Number of the document | 2861216 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13729029.2 |
| Date of filing the European patent application | 2013-06-14 | |
| (97) | Date of publication of the European application | 2015-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/062398 |
| Date | 2013-06-14 |
| (87) | Number | WO 2013/186370 |
| Date | 2013-12-19 |
| (30) | Number | Date | Country code |
| 1255593 | 2012-06-14 | FR |
| (72) |
AILHAS, Caroline, FR
HERRY, Catherine, FR
|
| (73) |
Ethypharm,
194 Bureaux de la Colline Bātiment D, 92210 Saint-Cloud,
FR
|
| (54) | FORMULATION PHARMACEUTIQUE ORALE DE MOLECULES BCS DE CLASSE III |
| ORAL PHARMACEUTICAL FORMULATION OF BCS CLASS III MOLECULES |